Related Experiment Video
Updated: May 16, 2026

Establishment of a Clinic-based Biorepository
Published on: May 29, 2017
Abnormal expression of PI3K isoforms in patients with tobacco-related oral squamous cell carcinoma
Richa Garg1, Vaishali Kapoor, Manasi Mittal
1Department of Biotechnology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi-110029, India.
Background:
The phosphatidylinositol 3-kinase (PI3K) signaling regulates several cellular functions such as motility, proliferation, angiogenesis and survival.
Methods:
Since there is no information on expression of PI3K isoforms in oral cancer, we studied the expression of different isoforms of PI3K (p110α, p110γ, PI3K-C2, Vps34p and p85α) in tumor samples and PBMC by RT and q-RTPCR and serum levels of PI3K p110α by SPR and ELISA techniques in 108 patients with tobacco-related oral squamous cell carcinoma (OSCC) and 46 normal subjects.
Results:
We observed significantly higher PI3K p110α (p<0.0001) and lower (p<0.0001) vesicular sorting protein 34p (Vps34p) mRNA both in PBMC and tissue samples of oral cancer patients as compared to the normal controls. Other PI3K isoforms did not show such change. Circulating PI3K p110α levels were higher in patients (p<0.0001) as compared to healthy subjects, the SPR data showed direct correlation with advancing stage of the disease. PI3K p110α was overexpressed in tumor samples but not in the normal buccal mucosa.
Conclusions:
Upregulation of circulating PI3K p110α isoform and its direct correlation with increasing tumor load in OSCC patients indicates that it may be a significant prognostic indicator and a suitable target for therapeutic/chemo-preventive strategies for tobacco-related OSCC.
Insights
Circulating phosphatidylinositol 3-kinase (PI3K) p110α is upregulated in oral squamous cell carcinoma (OSCC). Higher levels correlate with tumor progression, suggesting PI3K p110α as a prognostic marker for OSCC.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Phosphatidylinositol 3-kinase (PI3K) signaling pathways are crucial for cellular functions including proliferation and survival.
- Dysregulation of PI3K signaling is implicated in various cancers.
- Limited data exists on PI3K isoform expression in oral cancer.
Purpose of the Study:
- To investigate the expression of various PI3K isoforms in oral squamous cell carcinoma (OSCC).
- To determine the potential of PI3K isoforms as biomarkers for tobacco-related OSCC.
Main Methods:
- Studied PI3K isoforms (p110α, p110γ, PI3K-C2, Vps34p, p85α) in tumor tissues and peripheral blood mononuclear cells (PBMCs) from 108 OSCC patients and 46 controls.
- Utilized RT-qPCR for mRNA expression analysis.
- Measured serum PI3K p110α levels using Surface Plasmon Resonance (SPR) and ELISA.
Main Results:
- Significantly higher PI3K p110α mRNA and lower Vps34p mRNA were observed in OSCC patients' PBMCs and tissues compared to controls.
- Elevated circulating PI3K p110α levels were detected in OSCC patients.
- SPR data revealed a direct correlation between PI3K p110α levels and advancing disease stage.
- PI3K p110α overexpression was specific to tumor samples, not normal buccal mucosa.
Conclusions:
- Upregulation of circulating PI3K p110α isoform in OSCC patients correlates with tumor burden.
- PI3K p110α may serve as a significant prognostic indicator for tobacco-related OSCC.
- PI3K p110α represents a potential therapeutic and chemo-preventive target for OSCC.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
Abnormal Proliferation
